Allianz Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $117M | Buy |
208,153
+750
| +0.4% | +$421K | 0.1% | 187 |
|
|
2026
Q1 | $117M | Sell |
207,403
-8,654
| -4% | -$5.55M | 0.12% | 165 |
|
|
2025
Q4 | $146M | Buy |
216,057
+141,967
| +192% | +$96.7M | 0.15% | 124 |
|
|
2025
Q3 | $47.3M | Sell |
74,090
-52,200
| -41% | -$31.7M | 0.05% | 349 |
|
|
2025
Q2 | $67.7M | Sell |
126,290
-11,874
| -9% | -$5.68M | 0.08% | 232 |
|
|
2025
Q1 | $58M | Sell |
138,164
-23,097
| -14% | -$10M | 0.08% | 266 |
|
|
2024
Q4 | $66.7M | Sell |
161,261
-7,059
| -4% | -$3.1M | 0.09% | 237 |
|
|
2024
Q3 | $85M | Sell |
168,320
-56,460
| -25% | -$27.4M | 0.12% | 181 |
|
|
2024
Q2 | $110M | Buy |
224,780
+3,321
| +1% | +$1.67M | 0.16% | 133 |
|
|
2024
Q1 | $120M | Sell |
221,459
-27,218
| -11% | -$14.9M | 0.18% | 126 |
|
|
2023
Q4 | $138M | Sell |
248,677
-46,495
| -16% | -$21.8M | 0.23% | 90 |
|
|
2023
Q3 | $129M | Buy |
295,172
+11,056
| +4% | +$5.51M | 0.22% | 86 |
|
|
2023
Q2 | $143M | Buy |
284,116
+39,637
| +16% | +$19M | 0.26% | 82 |
|
|
2023
Q1 | $122M | Buy |
244,479
+93,464
| +62% | +$44.7M | 0.22% | 94 |
|
|
2022
Q4 | $61.6M | Sell |
151,015
-8,619
| -5% | -$3.35M | 0.12% | 164 |
|
|
2022
Q3 | $52M | Sell |
159,634
-98,464
| -38% | -$36.2M | 0.11% | 197 |
|
|
2022
Q2 | $90.5M | Sell |
258,098
-17,590
| -6% | -$7.17M | 0.09% | 266 |
|
|
2022
Q1 | $151M | Sell |
275,688
-8,044
| -3% | -$4.23M | 0.11% | 189 |
|
|
2021
Q4 | $187M | Sell |
283,732
-12,359
| -4% | -$7.76M | 0.13% | 175 |
|
|
2021
Q3 | $184M | Sell |
296,091
-18,923
| -6% | -$12.7M | 0.14% | 152 |
|
|
2021
Q2 | $199M | Buy |
315,014
+62,710
| +25% | +$34.6M | 0.17% | 132 |
|
|
2021
Q1 | $123M | Buy |
252,304
+75,496
| +43% | +$37.8M | 0.12% | 178 |
|
|
2020
Q4 | $88.4M | Buy |
176,808
+81,156
| +85% | +$36.3M | 0.09% | 232 |
|
|
2020
Q3 | $37.6M | Buy |
95,652
+1,723
| +2% | +$637K | 0.04% | 388 |
|
|
2020
Q2 | $31M | Buy |
93,929
+3,673
| +4% | +$1.06M | 0.04% | 470 |
|
|
2020
Q1 | $21.9M | Buy |
90,256
+8,856
| +11% | +$2.31M | 0.03% | 525 |
|
|
2019
Q4 | $21.3M | Sell |
81,400
-5,102
| -6% | -$1.34M | 0.02% | 762 |
|
|
2019
Q3 | $23.5M | Buy |
86,502
+17,736
| +26% | +$4.94M | 0.02% | 711 |
|
|
2019
Q2 | $18.9M | Buy |
68,766
+4,786
| +7% | +$1.18M | 0.02% | 834 |
|
|
2019
Q1 | $14.3M | Buy |
63,980
+4,809
| +8% | +$993K | 0.01% | 930 |
|
|
2018
Q4 | $11M | Sell |
59,171
-3,077
| -5% | -$631K | 0.01% | 1061 |
|
|
2018
Q3 | $15.5M | Sell |
62,248
-2,339
| -4% | -$568K | 0.01% | 1040 |
|
|
2018
Q2 | $14.1M | Sell |
64,587
-17,126
| -21% | -$3.53M | 0.01% | 1077 |
|
|
2018
Q1 | $15.6M | Buy |
81,713
+8,664
| +12% | +$1.6M | 0.01% | 1020 |
|
|
2017
Q4 | $11.4M | Sell |
73,049
-106,430
| -59% | -$16.8M | 0.01% | 1262 |
|
|
2017
Q3 | $27.9M | Buy |
179,479
+39,016
| +28% | +$6.17M | 0.02% | 812 |
|
|
2017
Q2 | $22.6M | Sell |
140,463
-28,577
| -17% | -$4.64M | 0.02% | 903 |
|
|
2017
Q1 | $26.1M | Buy |
169,040
+8,652
| +5% | +$1.19M | 0.03% | 858 |
|
|
2016
Q4 | $18.8M | Buy |
160,388
+94,456
| +143% | +$10.8M | 0.02% | 1037 |
|
|
2016
Q3 | $7.38M | Buy |
65,932
+53,363
| +425% | +$5.62M | 0.01% | 1463 |
|
|
2016
Q2 | $1.17M | Buy |
+12,569
| New | +$1.08M | ﹤0.01% | 2132 |
|
|
2014
Q2 | – | Sell |
-3,440
| Closed | -$209K | – | 1975 |
|
|
2014
Q1 | $209K | Sell |
3,440
-3,160
| -48% | -$188K | ﹤0.01% | 1761 |
|
|
2013
Q4 | $351K | Buy |
+6,600
| New | +$347K | ﹤0.01% | 1619 |
|
Other funds holding IDXX
Allianz Asset Management's IDXX Position: Q2 2026 in Review
Allianz Asset Management increased its Idexx Laboratories (IDXX) stake by 0.36% in Q2 2026, buying an estimated $421K and bringing the position to 208,153 shares worth $117M. The position accounts for 0.1% of the portfolio, ranked #187.
Allianz Asset Management first reported a position in IDXX in Q4 2013 and has held it in 43 quarters since. The position peaked at $199M in Q2 2021. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Allianz Asset Management held 208,153 shares of Idexx Laboratories worth $117M as of Q2 2026.
- Allianz Asset Management bought 750 Idexx Laboratories shares in Q2 2026, an estimated $421K.
- Idexx Laboratories made up 0.1% of Allianz Asset Management's portfolio in Q2 2026, its #187 holding.
- Allianz Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 43 quarters since.
- Allianz Asset Management's Idexx Laboratories position peaked at $199M in Q2 2021.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.